CompletedNCT01912352
Gene-environment Interactions and Brain Functional Connectivity in Attention Deficit Hyperactivity Disorder
Medication studyAges 6–18ADHD
Understand this study
Who was this study for?
Listed age limits: 6 years to 18 years.
- Activities
- Medication described in the protocol
- Compensation
- Payment and expense reimbursement have not been verified.
Study information
Study start dateMay 2010
- Recruitment status
- Completed
- Enrollment listed in the registry
- 83
- Sponsor
- Seoul National University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Not clearly listed
- Locations
- Not clearly listed
- Age range
- From 6 Years to 18 Years
- Official registry ID
- NCT01912352
- Official title
Show the full official title
Gene-environment Interactions and Brain Functional Connectivity Associated With Norepinephrine System Genes in Attention Deficit Hyperactivity Disorder
Recruitment & locations
CompletedLocations not listed
Questions about this study
Who is behind this study?
The study sponsor is Seoul National University, a university.
Did this study involve medication?
Yes. The study involved medication, including Methylphenidate.
Who was this study for?
Listed age limits: 6 years to 18 years.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit meRelated studies
A 14 Week, Randomized, Placebo-Controlled Cross-Over Study of Methylphenidate Hydrochloride Controlled Release Capsules in Adult ADHD With and Without Anxiety Disorder Comorbidity
A 40-week, randomized, double-blind, placebo-controlled, multicenter efficacy and safety study of Ritalin® LA in the treatment of adult patients with childhood-onset ADHD